#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Inositol 1,4,5-trisphosphate receptors are essential for fetal-maternal connection and embryo viability


Authors: Feili Yang aff001;  Lei Huang aff002;  Alexandria Tso aff003;  Hong Wang aff001;  Li Cui aff003;  Lizhu Lin aff003;  Xiaohong Wang aff004;  Mingming Ren aff002;  Xi Fang aff003;  Jie Liu aff005;  Zhen Han aff002;  Ju Chen aff003;  Kunfu Ouyang aff001
Authors place of work: School of Chemical Biology and Biotechnology, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, China aff001;  Department of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen, China aff002;  University of California San Diego, School of Medicine, Department of Medicine, La Jolla, CA, United States of America aff003;  Department of Pharmacology, Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China aff004;  Department of Pathophysiology, School of Medicine, Shenzhen University, Shenzhen, China aff005
Published in the journal: Inositol 1,4,5-trisphosphate receptors are essential for fetal-maternal connection and embryo viability. PLoS Genet 16(4): e32767. doi:10.1371/journal.pgen.1008739
Category: Research Article
doi: https://doi.org/10.1371/journal.pgen.1008739

Summary

Inositol 1,4,5‐trisphosphate receptors (IP3Rs) are a family of intracellular Ca2+ release channels located on the ER membrane, which in mammals consist of 3 different subtypes (IP3R1, IP3R2, and IP3R3) encoded by 3 genes, Itpr1, Itpr2, and Itpr3, respectively. Studies utilizing genetic knockout mouse models have demonstrated that IP3Rs are essential for embryonic survival in a redundant manner. Deletion of both IP3R1 and IP3R2 has been shown to cause cardiovascular defects and embryonic lethality. However, it remains unknown which cell types account for the cardiovascular defects in IP3R1 and IP3R2 double knockout (DKO) mice. In this study, we generated conditional IP3R1 and IP3R2 knockout mouse models with both genes deleted in specific cardiovascular cell lineages. Our results revealed that deletion of IP3R1 and IP3R2 in cardiomyocytes by TnT-Cre, in endothelial / hematopoietic cells by Tie2-Cre and Flk1-Cre, or in early precursors of the cardiovascular lineages by Mesp1-Cre, resulted in no phenotypes. This demonstrated that deletion of both IP3R genes in cardiovascular cell lineages cannot account for the cardiovascular defects and embryonic lethality observed in DKO mice. We then revisited and performed more detailed phenotypic analysis in DKO embryos, and found that DKO embryos developed cardiovascular defects including reduced size of aortas, enlarged cardiac chambers, as well as growth retardation at embryonic day (E) 9.5, but in varied degrees of severity. Interestingly, we also observed allantoic-placental defects including reduced sizes of umbilical vessels and reduced depth of placental labyrinth in DKO embryos, which could occur independently from other phenotypes in DKO embryos even without obvious growth retardation. Furthermore, deletion of both IP3R1 and IP3R2 by the epiblast-specific Meox2-Cre, which targets all the fetal tissues and extraembryonic mesoderm but not extraembryonic trophoblast cells, also resulted in embryonic lethality and similar allantoic-placental defects. Taken together, our results demonstrated that IP3R1 and IP3R2 play an essential and redundant role in maintaining the integrity of fetal-maternal connection and embryonic viability.

Keywords:

Embryos – Mouse models – Mesoderm – Growth restriction – Placenta – Trophoblasts – Somites

Introduction

Inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) are a family of intracellular Ca2+ release channels located on the membrane of endoplasmic reticulum (ER), which mediate Ca2+ mobilization from the ER to the cytoplasm when the receptors bind to the secondary messenger IP3 [1]. Three different subtypes of IP3Rs have been identified in mammals (IP3R1, IP3R2, and IP3R3) [2]. Using gene-knockout mouse models, IP3Rs have been shown to play an essential role in regulating diverse physiological processes, including brain function [3], taste perception [4], embryonic survival [57], extra-embryonic vascular development [7], exocrine secretion [8], T cell development [9], B cell function [10], gastrointestinal motility [11], vascular contractility and hypertension [12,13]. Interestingly, many of these studies demonstrated that IP3Rs are ubiquitously expressed and may function in a mechanism of redundancy between different subtypes [510,12,13]. In particular, IP3R1 and IP3R2 have been implied to play a role in regulating embryonic cardiac development. Deletion of both IP3R1 and IP3R2 caused developmental defects of ventricular myocardium and atrioventricular canal of the hearts, and embryonic lethality [6]. Since IP3R expression has been shown to occur before the appearance of ryanodine receptors in the early embryo [14], IP3R has been long proposed to drive the first cycling of Ca2+ within the heart and thus regulate embryonic cardiac development [15]. However, whether IP3R-mediated Ca2+ signaling was required for normal cardiac development and whether loss of IP3Rs in cardiovascular cell lineages could account for embryonic lethality of the IP3R1 and IP3R2 double knockout (DKO) mice remain unknown.

To address this question, we generated both conventional and tissue-specific IP3R1 and IP3R2 double knockout mouse models. Our results revealed that deletion of IP3R1 and IP3R2 in cardiomyocytes by TnT-Cre, in endothelial / hematopoietic cells by Tie2-Cre and Flk1-Cre, or in early precursors of the cardiovascular lineages by Mesp1-Cre, resulted in no embryonic lethal phenotypes, demonstrating that IP3R1 and IP3R2 in cardiovascular cell lineages are dispensable for embryonic survival. Subsequently, we observed the allantoic-placental defects that could occur independently from other phenotypes in DKO embryos. The placenta is a vital organ, which sits at the interface between the maternal and fetal circulation and facilitates the transport of nutrients and oxygen into the fetus [16]. The placenta is essential for survival and growth of the fetus during gestation, and placental dysfunction has been shown to result in various pregnancy diseases, fetal growth restriction, other pregnancy-associated disorders, and even embryonic death [17,18]. We found that the DKO embryos displayed reduced sizes of umbilical vessels and reduced depth of placental labyrinth. Furthermore, we generated a conditional IP3R1 and IP3R2 knockout mouse line utilizing the epiblast-specific Meox2-Cre (cKOMeox2), which targets all the fetal tissues and extraembryonic mesoderm but not extraembryonic trophoblast cells. The cKOMeox2 embryos displayed embryonic lethality and allantoic-placental defects, similar as DKO embryos, suggesting that epiblast cell lineages could, at least partially, account for the phenotypes observed in global IP3R1 and IP3R2 double knockout embryos. Taken together, our results demonstrated that IP3R1 and IP3R2 play an essential role in maintaining the integrity of fetal-maternal connection and embryonic viability.

Materials and methods

Mice

The generation of Itpr1 mutant (Itpr1-/-), Itpr1 floxed (Itpr1f/f), and Itpr2 mutant (Itpr2-/-) mice has been previously described, respectively [9,19,20]. The Itpr1+/-Itpr2-/- mice were generated and further intercrossed with each other to generate the global IP3R1 and IP3R2 double knockout (Itpr1-/-Itpr2-/-, DKO) and control (Itpr1+/+Itpr2-/-) mice. On the other hand, the Itpr1f/fItpr2-/- mice were crossed with the Tg(Tnnt2-cre)5Blh/JiaoJ (TnT-Cre; Jackson Laboratory) mice that express the Cre recombinase under the control of the rat cardiac troponin T2 [21], the B6.Cg-Tg(Tek-cre)1Ywa/J (Tie2-Cre; Jackson Laboratory) mice that have the mouse endothelial-specific receptor tyrosine kinase promoter directing expression of Cre recombinase [22], the Kdrtm1(cre)Sato/J (Flk1-Cre; Jackson Laboratory) mice that express the Cre recombinase under the control of the kinase insert domain protein receptor gene [23], the ICR.Cg-Mesp1tm2(cre)Ysa/YsaRbrc (Mesp1-Cre; International Mouse Strain Resource) mice that express the Cre recombinase under the control of endogenous promoter-enhancer [24], and the B6.129S4-Meox2tm1(cre)Sor/J (Meox2-Cre; Jackson Laboratory) mice that express the Cre recombinase under the control of the endogenous Meox2 promoter [25], to generate the cell / tissue-specific IP3R1 and IP3R2 double knockout mice, respectively. Briefly, male Cre+Itpr1f/+Itpr2-/- mice were generated and then crossed with female Cre-Itpr1f/fItpr2-/- mice for examination of the vaginal plug. Genotypic analysis was first performed at postnatal day 1 to see whether the offspring from each cross were born at Mendelian ratios. If embryonic lethality was suspected, embryos were then dissected at various embryonic stages. Otherwise, embryos were only collected at embryonic day (E) 10.5 for morphological analysis. Mesp1-Cre and Meox2-Cre mice were also crossed with the B6.129S4-Gt(ROSA)26Sortm1Sor/J (Rosa-LacZ; Jackson Laboratory) mice to generate Mesp1-Cre/Rosa-LacZ and Meox2-Cre/Rosa-LacZ mice for cell lineage tracing analysis, respectively.

DNA analysis

Genomic DNA was extracted from mouse tails or embryonic yolk sacs as previously described [26], and polymerase chain reaction (PCR) was utilized to genotype the mice using the following gene-specific primers (from 5’ to 3’): Itpr1 wildtype and floxed allele (forward, AGACCTCTGCCTTAGGA GGTATTT; reverse, ACTGGGCAGGCATATATAGTTAGC), Itpr1 mutant allele (forward, AGACCTCTG CCTTAGGAGGTATTT; reverse, TTTAAGAAAGCAAGGAGAAGGAGA), Itpr2 wildtype allele (forward, GCTGTGCCCAAAATCCTAGCACTG; reverse, CATGCAGAGGTCGTGTCAGTCATT), mutant allele (forward, AATGGGCTGACCGCTTCCTCGT; reverse, AGTGATACAGGGCAAGTTCATAC), TnT-Cre / Flk1-Cre (forward, GAGCATACCTGGAAAATGCTTC; reverse, CCGGCAAAACAGGTAGTTATTC), Tie2-Cre (forward, CCCTGTGCTCAGACAGAAATGAGA; reverse, CGCATAACCAGTGA AACAGCATTGC), Mesp1-Cre (forward, CTCTGAGCATGGTTCTTTCAAC; reverse, TCCCTGAA CATGTCCATCAGGTTC), Meox2-Cre (forward, ACCTCTCCCACACTTGACATCT; reverse, GAAGCATTTTCCAGGTATGCTC), Rosa-Laz (forward 1, AAAGTCGCTCTGAGTTGTTAT; forward 2, GCGAAGAGTTTGTCCTCAACC; reverse, GGAGCGGGAGAAATGGATATG).

Quantitative real time PCR analysis

The hearts and blood cells were collected from mouse embryos at E10.5, and total RNA was extracted using TRIzol reagent (Invitrogen). cDNA was synthesized using the TransScript One-Step cDNA Synthesis SuperMix Kit (Transgen Biotech). Quantitative real time PCR was then performed using TransStart Tip Green qPCR SuperMix (Transgen Biotech) according to the manufacturer’s instruction. The sequences for primers of Itpr1 and Gapdh were used as previously described [27]. Relative transcript abundance was normalized to Gapdh. Each sample was run at least in duplicate.

Morphological and histological analysis

Mice were mated under the standard 12-hour light / dark cycle, and noon on the day of the appearance of the vaginal plug was defined as the embryonic day 0.5 (E0.5). Embryos and placentas were dissected and collected under a Leica MZ6 dissecting light microscope and photographed as previously described [28]. The tissues were then fixed in 4% paraformaldehyde (PFA) diluted in phosphate buffered saline (PBS). For paraffin sections, the tissues were dehydrated through ethanol gradients and xylene, and embedded in paraffin. Serial sections (7 μm thick) were obtained and stained with hematoxylin and eosin (H&E) as previously described [29]. For frozen sections, tissues were incubated in a graded series of sucrose concentrations from 15% to 25%, and then embedded in optimal cutting temperature (OCT) compound (Sakura Finetek USA Inc., Torrance, CA, USA).

Whole-mount RNA in situ hybridization

In situ hybridization was performed using digoxigenin-labeled antisense riboprobes against Itpr1 (nucleotides 5051–6199, Genbank accession no. NM_010585.2), Itpr2 (nucleotides 4629–5644, Genbank accession no. NM_010586.1), and Itpr3 (nucleotides 7974–8733, Genbank, NM_080553.2). Briefly, embryos were collected and fixed in 4% PFA overnight, and then washed twice with PBS containing 0.1% Tween-20 (PBT). The embryos were dehydrated through a series of PBT-methanol washes and rehydrated through a reciprocal series of PBT-methanol washes. The embryos were then treated with 6% hydrogen peroxide diluted in PBT for 1 hour, followed by the digestion with 10μg/ml proteinase at room temperature for varied times depending on the stage of embryos. The digestion was stopped by 2 mg/ml glycine diluted in PBT. The samples were then post-fixed in 4% PFA, 0.2% glutaraldehyde and 0.1% Tween-20 for 20 minutes at room temperature, and prehybridized 2 hours in hybridization solution (50% formamide, 5X SSC, 1% SDS, 100 μg/ml yeast tRNA, 50 μg/ml heparin) at 65°C. After that, the embryos were incubated with fresh hybridization solution containing the digoxigenin-conjugated riboprobe at 65°C with rocking overnight. After hybridization, the embryos were washed twice with solution I (50% formamide, 5X SSC, 1% SDS) at 65°C (for 30 minutes each time), twice with solution II (50% formamide, 2X SSC) at 65°C (for 30 minutes each time), and then with TBST containing 140 mM NaCl, 2.5 mM KCl, 25 mM Tris, and 0.1% Tween-20. The embryos were then incubated with a blocking solution containing 1% blocking reagent at room temperature, followed by another incubation with a fresh blocking solution containing the anti-digoxigenin AP-conjugated antibody at 4°C. Finally, signals were detected using the NBT/BCIP solution and photographed under a stereomicroscope.

RNA in situ hybridization in cryosections

RNA in situ hybridization in cryosections was performed as previously described [30]. The probes against Hand1, Csh1 and Dlx3 are a kind gift from J.C. Cross. Sections (10 μm) were briefly rehydrated in PBS, post-fixed in 4% PFA, and treated with proteinase K (15 μg/ml) for various times depending on the ages of the embryos. The samples were then acetylated for 10 minutes in 0.25% (v/v) acetic anhydride, and hybridized with digoxigenin-conjugated riboprobes overnight at 65°C in sealed humidified boxes. After hybridization, the sections were treated with RNase, incubated with the blocking solution, and then treated with anti-digoxigenin AP-conjugated antibody. Signals were detected using the NBT/BCIP solution and photographed.

Whole-mount PECAM staining

Whole-mount PECAM staining was performed as previously described [28]. Briefly, the embryos dissected in ice cold PBS were fixed in 4% PFA overnight at 4°C. After fixation, the embryos were dehydrated in a graded methanol series (methanol concentrations of 25, 50, 75, and 100%, for 15 minutes each) at room temperature. After bleaching with 5% hydrogen peroxide in methanol for 4–5 hours, the embryos were then rehydrated using 75, 50, and 25% methanol and washed with PBS. After that, the embryos were incubated with the blocking solution for several hours at room temperature, and subsequently with the primary CD31 antibody (BD Pharmingen, catalog no. 550274) at 4°C overnight, followed by the incubation with the HRP-conjugated goat anti-rat IgG (Zsbio, catalog no.ZB2307) at 4°C overnight. The signals were developed using 3’,3’-diaminobenzidine, and photographed under a stereomicroscope.

X-gal staining

For whole-mount X-gal staining, mouse embryos and placentas were freshly collected and fixed in 4% PFA at 4°C for 1 hour, and then washed three times, each time with cold PBS for 10 minutes. The samples were subsequently stained in the X-gal solution containing 5 mM ferrocyanide, 5 mM ferricyanide, 2 mM MgCl2, 1 mg/ml X-gal, 0.01% sodium deoxycholate, 0.02% NP-40, for several hours at 37°C.

For cryosections, the tissues were freshly collected, fixed in 4% PFA, and embedded in OCT compound. Cryosections (10 μm) were prepared and stained with the X-gal solution. Nuclear Fast Red was used to counterstain the sections.

Transmission electron microscopy

Placentas were fixed with 2% PFA and 2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3). Specimens were post-fixed with 2% osmium tetroxide for 2 hours, stained with 3% uranyl acetate for 2 hours, and embedded in epoxy resin. Thin sections were cut, stained with uranyl acetate and lead citrate, and examined with transmission electron microscope.

Statistics

Scatter diagrams were drawn using Graphpad Prism 5. Statistical analysis was performed using a two-tailed, unpaired Student’s t test as previously described [31]. All data represent mean ± SEM (error bars). P < 0.05 was considered statistically significant.

Ethics statement

All mice were housed under a 12-hour day/night cycle at a temperature of 25°C. All animal care and experiments were conducted in accordance with the guidelines established by the Animal Care and Use Committee (IACUC) at Peking University Shenzhen Graduate School (Shenzhen, China), and approved by the IACUC (Approval #: AP0017). Periodic review of procedures was performed, and amendments were made as needed.

Results

Deletion of both IP3R1 and IP3R2 in mice caused growth retardation and embryonic lethality

To understand the role of IP3Rs in embryonic development, we first assessed expression of IP3R subtypes during early stages of embryonic development using RNA in situ hybridization (S1 Fig). IP3R subtypes were expressed in an overlapping fashion in mouse embryos including endocardium and atrioventricular cushions. In addition, distinct IP3R expression patterns were also observed in other embryonic domains, including pharyngeal arch arteries, sinus venosus, aortic endothelium, and forelimb (S1 Fig).

We then generated global IP3R1 and IP3R2 double knockout (Itpr1-/-Itpr2-/-, DKO) mouse model by intercrossing phenotypically normal Itpr1+/-Itpr2-/- mice (Fig 1A). Genotypic analysis revealed that no live DKO pups or embryos could be found after the embryonic day 14.5 (E14.5; Table 1). At E11.5, 4 of 44 embryos were identified as DKO pups, but all 4 of these DKO embryos were dead, developing no heart beat and undergoing reabsorption. On the other hand, DKO embryos were observed at the expected Mendelian ratio at E10.5, indicating that DKO embryos die sometime between E10.5 and E11.5, which is consistent with a previous study [6]. However, all DKO embryos at E10.5 developed apparent growth retardation and enlarged ventricles (Fig 1B), and most (21 off 23) DKO embryos developed chest edema, indicating cardiovascular dysfunction (Fig 1B). At E9.5, DKO embryos also exhibited growth retardation but with varied degrees when compared with their somite pair-matched control embryos (Fig 1B). The number of somite pairs in DKO embryos was significantly lower when their littermate control or Itpr1+/-Itpr2-/- embryos had somite pairs between 22–24 or above 25. On the other hand, numbers of somite pairs in DKO embryos were comparable when their littermate control embryos had less than 22 somite pairs (Fig 1C), thus indicating an age-dependent growth retardation in DKO embryos. In addition, histological assessment in control and DKO embryos at the stage of 23–24 somite pairs also revealed that DKO embryos with obvious growth retardation (3 off 11 DKO embryos) exhibited both enlarged cardiac chambers and reduced size of aortas when compared with control embryos, whereas DKO embryos with no obvious growth retardation at the same stage only exhibited reduced size of aortas (Fig 1D).

Generation and characterization of IP<sub>3</sub>R1 and IP<sub>3</sub>R2 double knockout mice.
Fig. 1. Generation and characterization of IP3R1 and IP3R2 double knockout mice.
(A) Schematic diagram of mouse breeding strategy used to generate Itpr1-/-Itpr2-/- (DKO) mice. The littermate Itpr1+/+Itpr2-/- mice were used as control. (B) Whole mount assessment of DKO and control mouse embryos at the stages of E10.5 and E9.5. At E9.5, somite pair-matched DKO and control embryos were collected at the stages of 27 somites (s27) and 23 somites (s23), respectively. Please note the varying degrees of growth retardation in DKO embryos at the stages of s27 (II, III) and s23 (V, VI) when compared to littermate controls (I, IV). Red arrows denote chest edema observed in both DKO embryos at E10.5 and one DKO embryo at the stage of s27. (C) Statistic analysis of somite pairs in DKO embryos and the littermate control and Itpr1+/-Itpr2-/- embryos at E9.5. According to the somite pair of control embryos, all embryos were divided into three groups, less than 22 (<22), between 22 and 25 (22–25), and above 25 (>25). n = 8–21 embryos for each group. All data represent mean ± SEM. Significance was determined by performing a two-tailed, unpaired Student’s t-test. **p < 0.01, ***p < 0.001 versus control. (D) Histological assessment of sectioned mouse embryos at the stage of s23 as shown in (B) following hematoxylin and eosin (H&E) staining. Chamber enlargement and wall thinning were also observed in DKO embryos (VI). ot, outflow tract; ao, aorta; ra, right atria; la, left atria; rv, right ventricle; lv, left ventricle. Black bar represents 0.25 mm.
Tab. 1. Genotypic analysis of embryos from Itpr1+/-Itpr2-/- x Itpr1+/-Itpr2-/- intercrosses.
Genotypic analysis of embryos from <i>Itpr1</i><sup>+/-</sup><i>Itpr2</i><sup>-/-</sup> x <i>Itpr1</i><sup>+/-</sup><i>Itpr2</i><sup>-/-</sup> intercrosses.

Deletion of IP3R genes in cardiovascular cell lineages did not cause embryonic lethality

We then investigated whether cells of cardiovascular origin were responsible for cardiovascular defects and embryonic lethality in DKO embryos. We first generated a series of conditional IP3R1 knockout mouse models in IP3R2 null background using cardiac muscle-specific expressing TnT-Cre [21], and endothelial / hematopoietic cell-specific expressing Tie2-Cre and Flk1-Cre [22,23]. It has been shown in our laboratory that TnT-Cre and Tie2-Cre are very efficient at deleting multiple floxed genes in mouse embryos [9,28,32,33]. We also performed quantitative real time PCR to examine expression of the Itpr1 gene, and found that Itpr1 mRNA levels were dramatically reduced in hearts of TnT-Cre+Itpr1f/fItpr2-/- embryos, and in blood cells of Tie2-Cre+Itpr1f/fItpr2-/- and Flk1-Cre+Itpr1f/fItpr2-/- embryos, when compared with those control embryos (S2A–S2C Fig). To our surprise, ablation of IP3R1 by TnT-Cre, Tie2-Cre or Flk1-Cre in IP3R2 null background did not result in any embryonic lethality (S1 Table). The embryos with conditional deletion of IP3R1 by TnT-Cre, Tie2-Cre or Flk1-Cre in IP3R2 null background were also phenotypically indistinguishable from control embryos at E10.5, exhibiting no growth retardation (Fig 2A–2C). Mesp1, a transcription factor of the b-HLH family, is the earliest marker of the cardiovascular lineages [34,35]. Cell lineage tracing analysis of Mesp1-Cre/Rosa-LacZ embryos and placentas at E9.5 have consistently shown that Mesp1-Cre can target the endothelium, endocardium, and myocardium in the embryonic heart, as well as the fetal endothelium from the allantoic capillaries in the placenta (S3A Fig). We also found that Itpr1 mRNA levels in hearts of Mesp1-Cre+Itpr1f/fItpr2-/- mice were significantly decreased when compared with those of Mesp1-Cre -Itpr1f/fItpr2-/- mice (S2D Fig). However, Mesp1-Cre mediated ablation of IP3R1 in IP3R2 null mice also did not cause any abnormality in embryonic development or embryonic lethality (Fig 2D; S3B Fig; S1 Table). Taken together, these results demonstrated that deletion of both IP3R1 and IP3R2 genes in cardiac cells, endothelial cells or even early precursors of the cardiovascular system is not responsible for early embryonic developmental defects observed in DKO mice. Therefore, our results indicate the alternative possibility that allantoic and/or placental defects may account for the embryonic lethality of DKO embryos.

Conditional deletion of IP<sub>3</sub>R1 in cardiovascular cell lineages in IP<sub>3</sub>R2 null mice.
Fig. 2. Conditional deletion of IP3R1 in cardiovascular cell lineages in IP3R2 null mice.
Cardiac specific TnT-Cre (A), endothelial / hematopoietic cell-specific Tie2-Cre (B) and Flk1-Cre (C), and Mesp1-Cre (D) that targets multiple cardiovascular cell lineages were used to delete IP3R1 gene in IP3R2-/- mice. Whole-mount morphological assessment of control versus conditional IP3R1 and IP3R2 double knockout mice at E10.5 revealed no growth retardation after deletion of both IP3R genes by TnT-Cre (n = 6), Tie2-Cre (n = 5), Flk1-Cre (n = 7), and Mesp1-Cre (n = 7).

DKO embryos developed allantoic-placental defects

The placenta and allantois play an essential role in sustaining fetal growth throughout the gestational period. In mice, placental development starts at embryonic day (E) 3.5 when the outer trophectoderm layer and the inner cell mass are formed [18]. At the time of implantation (E4.5), different trophoblast cell types begin to form. The allantois arises from the mesoderm at the posterior end of the embryo and joins to the chorion at E8.5 [36]. Once the distal end of the allantois is joined with the chorion, the chorion begins to fold, making a space where fetal blood vessels grow in from the allantois to generate the fetal components of the placental vasculature. The trophoblast, together with fetal blood vessels, undergoes extensive villous branching to generate the labyrinth that is supported by the spongiotrophoblast [37,38]. The maternal blood supply passes through the spongiotrophoblast via the maternal arterial sinuses, and the umbilical artery and vein connect the fetal vasculature of the placenta to the developing fetus [38,39]. Defects in the placenta development and function are known to lead to fetal growth retardation and, in more severe cases, secondary cardiac phenotypes and embryonic lethality [38,4042].

Indeed, we found that DKO embryos at E9.5 exhibited allantoic-placental abnormalities. To minimize the difference in embryonic body size, DKO and somite pair-matched control embryos with comparable growth were collected at E9.5 and examined. First of all, we found that the size/diameter of the umbilical vein that is located in the caudal trunk was significantly reduced in DKO embryos at E9.5, when compared with the somite pair-matched control embryos (Fig 3A; S4A and S4B Fig). Furthermore, the density of umbilical vein plexus was also dramatically decreased in DKO embryos, evidenced by the reduction of branches from the umbilical vein in DKO embryos when compared with control embryos (Fig 3A; S4C and S4D Fig). In addition, the size of the umbilical cord / allantois in DKO embryos was also apparently reduced at this stage (Fig 3B), which was further confirmed by histological assessment, evidenced by the reduction of the averaged perimeters of umbilical vessels in DKO embryos when compared with somite pair-matched control embryos (Fig 3C and 3D).

Deletion of both IP<sub>3</sub>R1 and IP<sub>3</sub>R2 resulted in developmental abnormalities in allantoic / umbilical vessels.
Fig. 3. Deletion of both IP3R1 and IP3R2 resulted in developmental abnormalities in allantoic / umbilical vessels.
(A) Whole-mount platelet endothelial cell adhesion molecule (PECAM) staining of fixed DKO and control embryos at the stages of 20 (s20) and 24 (s24) somite pairs at low and high magnifications. Please note reduced diameter of umbilical vein (red arrow) and reduced density of umbilical vein plexus (yellow star) in the caudal trunk in DKO embryos. (B, C) Whole-mount and transverse sections of umbilical cords in DKO and control mouse embryos at E9.5. The diameter of the allantois is outlined by two parallel dotted white lines. pl, placenta; em, embryo; uc, umbilical cord. The asterisks indicate the umbilical vessels. Black bar represents 70 μm. (D) Quantitative analysis showing that the averaged perimeter of two umbilical vessels was significantly reduced in DKO embryos (n = 6) when compared with control embryos (n = 7). All data represent mean ± SEM. Significance was determined by two-tailed, unpaired Student’s t-test. ***p < 0.001 versus control.

We also investigated whether DKO embryos developed placental defects. For this purpose, we then assessed expression of IP3R subtypes in mouse placenta and allantois at E8.5–9.5. IP3R1 and IP3R3 were both expressed in cells of the maternal decidua, chorion mesoderm, spongiotrophoblast, labyrinth layer of the placenta, and the allantois (S5A and S5C Fig). On the other hand, assessment of IP3R2 expression in placenta revealed uniform expression throughout the placenta and allantois at both E8.5 to E9.5 (S5B Fig). Whole-mount examination of DKO embryos between E8.0-E8.5 revealed that the extension and fusion of the allantois were indistinguishable from littermate controls (S6 Fig), suggesting that early events of placental development were unaffected in DKO embryos. However, histological examination of placenta from DKO embryos at E9.5 revealed a strikingly underdeveloped labyrinth layer when compared to littermate controls (Fig 4A and 4B; S2 Table). It has been shown that cell lineage derivatives from placental trophoblast and allantois mesoderm play a critical role in the establishment and maturation of the labyrinth layer [40,42]. Therefore, we next determined whether trophoblast cell specific markers, such as the basic helix-loop-helix transcription factor Hand1, chorionic somatomammotropin hormone 1 (Csh1) and the mammalian Distal-less homolog Dlx3 [4345], were affected in DKO placentas. Expression of Hand1, Csh1, and Dlx3 could be identified in both DKO and control placentas (S7 Fig), suggesting that trophoblast cell identify was unaffected after IP3R deficiency. However, expression of Dlx3, a specific marker of the trilaminar trophoblast layer, was much more restricted in DKO placentas compared to the controls (S7 Fig), which further highlights the labyrinth defect observed in DKO placentas.

Ablation of both IP<sub>3</sub>R1 and IP<sub>3</sub>R2 caused placental defects.
Fig. 4. Ablation of both IP3R1 and IP3R2 caused placental defects.
(A) Histological analysis of placental sections from E9.5 DKO and control embryos by H&E staining, at low (left) and high (right) magnification views. Trophoblast giant cell (gc), spongiotrophoblast (sp) and labyrinth (la) layers as well as chorion (ch) are shown within the placentas. The depth of the labyrinth is depicted by a vertical red bar. Red arrows denote the nucleated fetal blood cells. Black bar represents 0.2 mm (left) and 0.1 mm (right). (B) Quantitative analysis showing that the depth of the labyrinth is significantly reduced in DKO placentas (n = 5) when compared with control placentas (n = 6). All data represent mean ± SEM. Significance was determined by two-tailed, unpaired Student’s t-test. ***p < 0.001 versus control. (C) Ultrastructural analysis of the trophoblast barrier in E9.5 DKO and control labyrinth layer. Representative micrographs from DKO and control labyrinth layers at E9.5 at low (left) and high (right) magnification views. Fetal allantoic endothelial cells (en), maternal blood cells (m), fetal blood cells (f), the first (I), second (II), and third (III) layers of the trilaminar trophoblast layer are shown. Adjacent layers are tightly packed and intimately associated with a compacted fetal allantoic endothelium (en) in control placenta. Please note the dissociation between the fetal allantoic endothelial cells and layer III of the trilaminar trophoblast layer in the DKO placenta. Black bar represents 5 μm (left) and 1 μm (right).

In addition, ultrastructural analysis of DKO placentas at E9.5 revealed the dissociation between fetal allantoic endothelium and syncytiotrophoblast layer III of the trilaminar trophoblast layer (Fig 4C), which was in contrast to the littermate controls, which exhibited an intimate association between the compacted fetal allantoic endothelium and the trilaminar trophoblast layer (Fig 4C), suggesting that deletion of both IP3R1 and IP3R2 in mice is required for maintaining the chorio-allantoic integrity.

Epiblast-specific deletion of IP3R1 in IP3R2 null background results in embryonic lethality and placental defects

We next determined whether IP3Rs within cells from epiblast lineages, which give rise to the allantois, chorionic mesoderm, and embryo [4648], were required for embryonic viability. We thus ablated IP3R1 in IP3R2 null background utilizing Meox2-Cre, which is active in cells of the epiblast, but is not active in primitive endoderm or trophectoderm [25]. Consistently, cell lineage tracing analysis at E9.5 Meox2-Cre/Rosa-LacZ embryos and placentas revealed that Meox2-Cre activity was highly efficient in all cells of E9.5 embryos including extraembryonic vascular and mesenchymal cells, and chorionic mesoderm, but not in extraembryonic trophoblast cells (Fig 5A). It is important to note that Meox2-Cre mediated excision of IP3R1 in IP3R2 null (cKOMeox2) mice also resulted in similar but slightly late-onset allantoic-placental phenotypes and embryonic lethality (Fig 5B; Table 2), when compared with global DKO embryos. At E10.5, cKOMeox2 embryos also exhibited a dramatic decrease in the diameter of the umbilical cord (Fig 5B). Furthermore, an underdeveloped labyrinth layer was also observed in placentas of cKOMeox2 embryos at E10.5 when compared to the littermate controls (Fig 5C and 5D). These results all suggested that epiblast cell lineages could, at least partially, account for the phenotype of global IP3R1 and IP3R2 double knockout embryos.

IP<sub>3</sub>R1 and IP<sub>3</sub>R2 deletion in the epiblast causes placental defects.
Fig. 5. IP3R1 and IP3R2 deletion in the epiblast causes placental defects.
(A) Whole mount lacZ staining and transverse sections counterstained with nuclear fast red in E9.5 Meox2-Cre/Rosa-lacZ embryos and placentas. Low and high magnification views of the umbilical cord were presented to highlight the contribution of Meox2-Cre derived cells in the umbilical cord and placenta. em, embryo; pl, placenta; uc, umbilical cord; ma, maternal decidua; ch, chorion; gc, trophoblast giant cell; sp, spongiotrophoblast; la, labyrinth; en, endothelial cell; tp, trophoblast cell; me, mesenchymal cell. Black bar represents 0.4 mm. (B) Whole-mount assessment of E10.5 control and Meox2-Cre+Itpr1f/fIptr2-/- (cKOMeox2) embryos. The diameter of the umbilical cord is outlined by two parallel dotted yellow lines. Please note chest edema (yellow arrow) in cKOMeox2 embryos. (C) Histological analysis of placental sections from E10.5 cKOMeox2 and control embryos by H&E staining, at low (left) and high (right) magnification views. Trophoblast giant cell (gc), spongiotrophoblast (sp) and labyrinth (la) layers as well as chorion (ch) are shown within the placentas. The depth of the labyrinth is depicted by a vertical yellow bar. Yellow arrows denote the nucleated fetal blood cells. Black bar represents 0.4 mm (left) and 0.1 mm (right). (D) Quantitative analysis showing that the depth of the labyrinth is significantly reduced in E10.5 cKOMeox2 placentas (n = 6) when compared with control placentas (n = 6). All data represent mean ± SEM. Significance was determined by two-tailed, unpaired Student’s t-test. ***p < 0.001 versus control.
Tab. 2. Genotypic analysis of embryos from Meox2-Cre+Itpr1f/+Itpr2-/- x Itpr1f/fItpr2-/- intercrosses.
Genotypic analysis of embryos from <i>Meox2-Cre</i><sup>+</sup><i>Itpr1</i><sup>f/+</sup><i>Itpr2</i><sup>-/-</sup> x <i>Itpr1</i><sup>f/f</sup><i>Itpr2</i><sup>-/-</sup> intercrosses.

Discussion

In this study, we investigated the role of IP3R1 and IP3R2 in embryonic development and survival using both conventional and tissue-specific gene knockout strategies. We demonstrated that ablation of both IP3R1 and IP3R2 resulted in growth retardation and embryonic lethality at around E10.5. A previous study also showed that deletion of both IP3R1 and IP3R2 caused death of mutant embryos around E10.5 [6]; in a subset of E9.5 DKO embryos which had already developed obvious growth retardation, we observed similar cardiac defects as previously reported [6], including enlarged ventricles and thinner ventricular walls. Our study also revealed no obvious cardiac defects in DKO embryos that did not develop obvious growth retardation at E9.5. Furthermore, our results also demonstrated that cardiac cell-specific deletion of IP3R1 in IP3R2 null background genes did not cause any growth retardation and embryonic lethality, suggesting that IP3R1 and IP3R2 in cardiac cells are dispensable for embryonic development, which also implicated that cardiac defects observed in DKO embryos might be secondary to the allantoic-placental defects observed in DKO embryos.

On the other hand, placental defects strongly correlate with abnormal heart, brain and vascular development, even though the mechanistic relationship between these systems has not been fully understood [17,49]. In our study, allantoic-placental defects could be detected in all DKO embryos, even those without obvious growth retardation, implicating that allantoic-placental defects could precede cardiovascular abnormalities in DKO embryos. These allantoic-placental defects observed in DKO embryos included (1) reduced size of umbilical veins and less umbilical vein plexus in the posterior trunk, (2) smaller umbilical cord and reduced diameter of both umbilical vein and artery, (3) underdeveloped labyrinth layer in the placenta, and (4) diminished connection between endothelium of fetal allantoic capillary and the trilaminar trophoblast layer. All these abnormalities in DKO embryos could lead to insufficient metabolic exchange and eventually embryonic lethality.

It has been suggested that Ca2+ signaling pathways might be involved in regulating the establishment of fetal-maternal connection. PLCδ1/PLCδ3 double-knockout mice exhibited decreased vascularization in the labyrinth layer of the placenta and abnormal proliferation and apoptosis of trophoblasts [50]. Na+-Ca2+ exchanger 1 (NCX1), a key plasma membrane Ca2+ transporter, was also involved in both cardiac and placental development. NCX1 knockout mice developed both cardiac defects and an underdeveloped labyrinth layer [51,52], but it is important to note that cardiac specific-expression of NCX1 in NCX1 knockout mice could only rescue cardiac defects, not placental defects [53]. Furthermore, the study by Uchida et al [7], also showed that double knockout of IP3R1 and IP3R3 caused embryonic lethality at a similar stage to that of our IP3R1 and IP3R2 double knockout mice. Uchida et al also observed that deletion of IP3R1 and IP3R3 resulted in abnormal vascular development in the allantois and disorganized placenta. Although their results suggested that inhibition of IP3Rs in cultured endothelial cells could affect tube formation and cell migration, they did not generate endothelial cell-specific IP3R1 and IP3R3 knockout mice for further characterization. Our results showing no phenotype in mice with deletion of IP3R1 by Tie2-Cre and Flk1-Cre in IP3R2 null background make it unlikely that loss of IP3R1 and IP3R2 in endothelial cells could account for vascular defects observed in the global knockout embryos.

In our present study, we utilized the cell / tissue specific gene deletion strategy to investigate the cell dependent mechanism underlying how IP3R1 and IP3R2 regulate the allantoic-placental development. Firstly, endothelial / hematopoietic cell-specific deletion of IP3R1 in IP3R2 null background did not cause similar developmental defects and embryonic lethality in mice. Secondly, ablation of IP3R1 in IP3R2 null background by Mesp1-Cre, which is mainly expressed in anterior mesoderm targeting multiple cardiovascular lineages [34,35], also did not cause embryonic developmental defect and embryonic death. These results together strongly suggested that vascular abnormalities observed in DKO embryos might be secondary to the allantoic / placental defects. Indeed, expression of all three IP3R subtypes could be found in the placenta, including the allantois, chorion mesoderm, and trophoblast cells. Trophoblast cells are derived from the trophectoderm that constitutes the outer layer of the blastocyst and segregates from the inner cell mass [54], and defects in trophoblast differentiation and function have been shown to cause embryonic lethality [45,55,56]. On the other hand, the inner cell mass gives rise to primitive endoderm (hypoblast) and primitive ectoderm (epiblast), and the latter forms all the fetal tissues, both somatic and germline, as well as the amnion ectoderm and all the extraembryonic mesoderm [46,47]. It is important to note that epiblast-specific deletion of IP3R1 by Meox2-Cre in IP3R2 null background also resulted in similar allantoic-placental defects in mice, even including the slight delay in embryonic death compared to conventional global DKO embryos. Although it remains unclear whether deletion of IP3Rs in trophoblast cells could also contribute to the developmental abnormalities observed in DKO embryos, our results have at least demonstrated that IP3R1 and IP3R2 in epiblast cell lineages are required for normal embryonic development and survival. It is worthy to note that deletion of IP3R1 by Meox2-Cre but not Mesp1-Cre in IP3R2 null background could cause allantoic-placental defects and embryonic lethality. Mesp1-Cre activity has been shown to partially overlap with that of Meox2-Cre [24,25,35], but our cell lineage tracing also revealed that the latter could target both allantois-derived extraembryonic mesenchymal cells and chorionic mesoderm more efficiently. In this context, it will be very interesting, in future studies, to investigate whether IP3Rs in allantois-derived cells or chorionic mesoderm could account for the allantoic-placental defects in the DKO embryos.

Supporting information

S1 Fig [tif]
Expression of IPR subtypes in mouse embryos at early developmental stages.

S2 Fig [tif]
Characterization of mRNA levels in conditional gene knockout mouse models.

S3 Fig [a]
Deletion of IPR1 by Mesp1-Cre in IPR2 null background does not alter embryonic development.

S4 Fig [tif]
Quantitative analysis of vascular development in control and DKO embryos.

S5 Fig [a]
Expression of IPR subtypes in mouse placentas at early developmental stages.

S6 Fig [tif]
Macroscopic assessment of allantois extension and fusion in DKO mouse embryos.

S7 Fig [tif]
Expression of trophoblast cell-specific marker in control and DKO placentas.

S1 Table [p1]
Genotypic analysis of embryos for generation of cell / tissue specific IPR1 and IPR2 knockout mice.

S2 Table [docx]
Summary of embryonic phenotypes observed in IPR1 and IPR2 double knockout embryos between E9.5 and E11.5.


Zdroje

1. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature. 1993;361(6410):315–25. doi: 10.1038/361315a0 8381210.

2. Foskett JK, White C, Cheung K-H, Mak D-OD. Inositol Trisphosphate Receptor Ca2+ Release Channels. Physiological Reviews. 2007;87(2):593–658. doi: 10.1152/physrev.00035.2006 17429043

3. Sakakibara S, Nagata E, Takano H, Matsumoto M, Yamada M, Nakagawa T, et al. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature. 1996;379(6561):168–71. doi: 10.1038/379168a0 8538767

4. Hisatsune C, Yasumatsu K, Takahashi-Iwanaga H, Ogawa N, Kuroda Y, Yoshida R, et al. Abnormal Taste Perception in Mice Lacking the Type 3 Inositol 1,4,5-Trisphosphate Receptor. Journal of Biological Chemistry. 2007;282(51):37225–31. doi: 10.1074/jbc.M705641200 17925404

5. Nakazawa M, Uchida K, Aramaki M, Kodo K, Yamagishi C, Takahashi T, et al. Inositol 1,4,5-trisphosphate receptors are essential for the development of the second heart field. Journal of Molecular and Cellular Cardiology. 2011;51(1):58–66. doi: 10.1016/j.yjmcc.2011.02.014 21382375

6. Uchida K, Aramaki M, Nakazawa M, Yamagishi C, Makino S, Fukuda K, et al. Gene knock-outs of inositol 1,4,5-trisphosphate receptors types 1 and 2 result in perturbation of cardiogenesis. PloS one. 2010;5(9):e12500. doi: 10.1371/journal.pone.0012500 20824138

7. Uchida K, Nakazawa M, Yamagishi H, Yamagishi C, Mikoshiba K. Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. Developmental Biology. 2016;418(1):89–97. doi: 10.1016/j.ydbio.2016.08.007 27514653

8. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, et al. IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science (New York, NY). 2005;309(5744):2232–4. doi: 10.1126/science.1114110 16195467

9. Ouyang K, Leandro Gomez-Amaro R, Stachura DL, Tang H, Peng X, Fang X, et al. Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia. Nature communications. 2014;5(1):4814–. doi: 10.1038/ncomms5814 25215520

10. Tang H, Wang H, Lin Q, Fan F, Zhang F, Peng X, et al. Loss of IP3 Receptor–Mediated Ca2+ Release in Mouse B Cells Results in Abnormal B Cell Development and Function. The Journal of Immunology. 2017;199(2):570–80. doi: 10.4049/jimmunol.1700109 28615414

11. Wang H, Jing R, Trexler C, Li Y, Tang H, Pan Z, et al. Deletion of IP3R1 by Pdgfrb-Cre in mice results in intestinal pseudo-obstruction and lethality. J Gastroenterol. 2019;54(5):407–18. doi: 10.1007/s00535-018-1522-7 30382364.

12. Lin Q, Zhao G, Fang X, Peng X, Tang H, Wang H, et al. IP3 receptors regulate vascular smooth muscle contractility and hypertension. JCI Insight. 2016;1(17). doi: 10.1172/jci.insight.89402 27777977

13. Lin Q, Zhao L, Jing R, Trexler C, Wang H, Li Y, et al. Inositol 1,4,5-Trisphosphate Receptors in Endothelial Cells Play an Essential Role in Vasodilation and Blood Pressure Regulation. J Am Heart Assoc. 2019;8(4):e011704. doi: 10.1161/JAHA.118.011704 30755057; PubMed Central PMCID: PMC6405661.

14. Mery A, Aimond F, Menard C, Mikoshiba K, Michalak M, Puceat M. Initiation of embryonic cardiac pacemaker activity by inositol 1,4,5-trisphosphate-dependent calcium signaling. Mol Biol Cell. 2005;16(5):2414–23. doi: 10.1091/mbc.E04-10-0883 15758029; PubMed Central PMCID: PMC1087245.

15. Roderick HL, Bootman MD. Pacemaking, arrhythmias, inotropy and hypertrophy: the many possible facets of IP3 signalling in cardiac myocytes. J Physiol. 2007;581(Pt 3):883–4. doi: 10.1113/jphysiol.2007.133819 17446217; PubMed Central PMCID: PMC2170819.

16. Hemberger M, Hanna CW, Dean W. Mechanisms of early placental development in mouse and humans. Nat Rev Genet. 2019. doi: 10.1038/s41576-019-0169-4 31534202.

17. Burton GJ, Jauniaux E. Development of the Human Placenta and Fetal Heart: Synergic or Independent? Frontiers in physiology. 2018;9:373. doi: 10.3389/fphys.2018.00373 29706899

18. Copp AJ. Death before birth: clues from gene knockouts and mutations. Trends Genet. 1995;11(3):87–93. doi: 10.1016/S0168-9525(00)89008-3 7732578.

19. Cooley N, Ouyang K, McMullen JR, Kiriazis H, Sheikh F, Wu W, et al. No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy. Circ Heart Fail. 2013;6(2):318–25. doi: 10.1161/CIRCHEARTFAILURE.112.972158 23258573; PubMed Central PMCID: PMC4028972.

20. Wang YJ, Huang J, Liu W, Kou X, Tang H, Wang H, et al. IP3R-mediated Ca2+ signals govern hematopoietic and cardiac divergence of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway. J Mol Cell Biol. 2017;9(4):274–88. doi: 10.1093/jmcb/mjx014 28419336.

21. Jiao K, Kulessa H, Tompkins K, Zhou Y, Batts L, Baldwin HS, et al. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev. 2003;17(19):2362–7. doi: 10.1101/gad.1124803 12975322; PubMed Central PMCID: PMC218073.

22. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001;230(2):230–42. doi: 10.1006/dbio.2000.0106 11161575.

23. Motoike T, Markham DW, Rossant J, Sato TN. Evidence for novel fate of Flk1+ progenitor: contribution to muscle lineage. Genesis. 2003;35(3):153–9. doi: 10.1002/gene.10175 12640619.

24. Saga Y, Miyagawa-Tomita S, Takagi A, Kitajima S, Miyazaki Ji, Inoue T. MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development. 1999;126(15):3437. 10393122

25. Tallquist MD, Soriano P. Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis. 2000;26(2):113–5. doi: 10.1002/(sici)1526-968x(200002)26:2<113::aid-gene3>3.0.co;2-2 10686601.

26. Fan F, Duan Y, Yang F, Trexler C, Wang H, Huang L, et al. Deletion of heat shock protein 60 in adult mouse cardiomyocytes perturbs mitochondrial protein homeostasis and causes heart failure. Cell Death Differ. 2019. Epub 2019/06/19. doi: 10.1038/s41418-019-0374-x 31209364.

27. Lin Q, Zhao G, Fang X, Peng X, Tang H, Wang H, et al. IP3 receptors regulate vascular smooth muscle contractility and hypertension. JCI Insight. 2016;1(17):e89402 Epub 2016/10/26. doi: 10.1172/jci.insight.89402 [pii]. 27777977; PubMed Central PMCID: PMC5070959.

28. Duan Y, Wang H, Mitchell-Silbaugh K, Cai S, Fan F, Li Y, et al. Heat shock protein 60 regulates yolk sac erythropoiesis in mice. Cell Death Dis. 2019;10(10):766. doi: 10.1038/s41419-019-2014-2 31601784; PubMed Central PMCID: PMC6786998.

29. Fang X, Stroud MJ, Ouyang K, Fang L, Zhang J, Dalton ND, et al. Adipocyte-specific loss of PPARgamma attenuates cardiac hypertrophy. JCI Insight. 2016;1(16):e89908. doi: 10.1172/jci.insight.89908 27734035; PubMed Central PMCID: PMC5053146.

30. Simmons DG, Fortier AL, Cross JC. Diverse subtypes and developmental origins of trophoblast giant cells in the mouse placenta. Dev Biol. 2007;304(2):567–78. doi: 10.1016/j.ydbio.2007.01.009 17289015.

31. Fang X, Bogomolovas J, Zhou PS, Mu Y, Ma X, Chen Z, et al. P209L mutation in Bag3 does not cause cardiomyopathy in mice. Am J Physiol Heart Circ Physiol. 2019;316(2):H392–H9. doi: 10.1152/ajpheart.00714.2018 30499714; PubMed Central PMCID: PMC6397380.

32. Zhang Z, Mu Y, Zhang J, Zhou Y, Cattaneo P, Veevers J, et al. Kindlin-2 Is Essential for Preserving Integrity of the Developing Heart and Preventing Ventricular Rupture. Circulation. 2019;139(12):1554–6. doi: 10.1161/CIRCULATIONAHA.118.038383 30883226; PubMed Central PMCID: PMC6424132.

33. Wu T, Mu Y, Bogomolovas J, Fang X, Veevers J, Nowak RB, et al. HSPB7 is indispensable for heart development by modulating actin filament assembly. Proc Natl Acad Sci U S A. 2017;114(45):11956–61. doi: 10.1073/pnas.1713763114 29078393; PubMed Central PMCID: PMC5692592.

34. Saga Y, Hata N, Kobayashi S, Magnuson T, Seldin MF, Taketo MM. MesP1: a novel basic helix-loop-helix protein expressed in the nascent mesodermal cells during mouse gastrulation. Development. 1996;122(9):2769. 8787751

35. Saga Y, Kitajima S, Miyagawa-Tomita S. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med. 2000;10(8):345–52. doi: 10.1016/s1050-1738(01)00069-x 11369261.

36. Downs KM, Harmann C. Developmental potency of the murine allantois. Development. 1997;124(14):2769–80. 9226448.

37. Basyuk E, Cross JC, Corbin J, Nakayama H, Hunter P, Nait-Oumesmar B, et al. Murine Gcm1 gene is expressed in a subset of placental trophoblast cells. Dev Dyn. 1999;214(4):303–11. doi: 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.0.CO;2-B 10213386.

38. Inman KE, Downs KM. The murine allantois: emerging paradigms in development of the mammalian umbilical cord and its relation to the fetus. Genesis. 2007;45(5):237–58. doi: 10.1002/dvg.20281 17440924.

39. Li Y, Behringer RR. Esx1 is an X-chromosome-imprinted regulator of placental development and fetal growth. Nat Genet. 1998;20(3):309–11. doi: 10.1038/3129 9806555.

40. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nature reviews Genetics. 2001;2(7):538–48. doi: 10.1038/35080570 11433360

41. Watson ED, Cross JC. Development of Structures and Transport Functions in the Mouse Placenta. Physiology. 2005;20(3):180–93. doi: 10.1152/physiol.00001.2005 15888575

42. Watson ED, Cross JC. Development of structures and transport functions in the mouse placenta. Physiology (Bethesda). 2005;20:180–93. doi: 10.1152/physiol.00001.2005 15888575.

43. Scott IC, Anson-Cartwright L, Riley P, Reda D, Cross JC. The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms. Mol Cell Biol. 2000;20(2):530–41. doi: 10.1128/mcb.20.2.530-541.2000 10611232; PubMed Central PMCID: PMC85124.

44. Faria TN, Ogren L, Talamantes F, Linzer DI, Soares MJ. Localization of placental lactogen-I in trophoblast giant cells of the mouse placenta. Biol Reprod. 1991;44(2):327–31. doi: 10.1095/biolreprod44.2.327 2009333.

45. Morasso MI, Grinberg A, Robinson G, Sargent TD, Mahon KA. Placental failure in mice lacking the homeobox gene Dlx3. Proc Natl Acad Sci U S A. 1999;96(1):162–7. doi: 10.1073/pnas.96.1.162 9874789; PubMed Central PMCID: PMC15110.

46. Gardner RL. Clonal analysis of early mammalian development. Philos Trans R Soc Lond B Biol Sci. 1985;312(1153):163–78. doi: 10.1098/rstb.1985.0186 2869527.

47. Lawson KA, Meneses JJ, Pedersen RA. Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development. 1991;113(3):891–911. 1821858.

48. Downs KM, Temkin R, Gifford S, McHugh J. Study of the murine allantois by allantoic explants. Dev Biol. 2001;233(2):347–64. doi: 10.1006/dbio.2001.0227 11336500.

49. Perez-Garcia V, Fineberg E, Wilson R, Murray A, Mazzeo CI, Tudor C, et al. Placentation defects are highly prevalent in embryonic lethal mouse mutants. Nature. 2018;555(7697):463–8. doi: 10.1038/nature26002 29539633

50. Nakamura Y, Hamada Y, Fujiwara T, Enomoto H, Hiroe T, Tanaka S, et al. Phospholipase C-delta1 and -delta3 are essential in the trophoblast for placental development. Mol Cell Biol. 2005;25(24):10979–88. doi: 10.1128/MCB.25.24.10979-10988.2005 16314520; PubMed Central PMCID: PMC1316982.

51. Cho CH, Kim SS, Jeong MJ, Lee CO, Shin HS. The Na+ -Ca2+ exchanger is essential for embryonic heart development in mice. Mol Cells. 2000;10(6):712–22. doi: 10.1007/s10059-000-0712-2 11211878.

52. Wakimoto K, Kobayashi K, Kuro OM, Yao A, Iwamoto T, Yanaka N, et al. Targeted disruption of Na+/Ca2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat. J Biol Chem. 2000;275(47):36991–8. doi: 10.1074/jbc.M004035200 10967099.

53. Cho CH, Lee SY, Shin HS, Philipson KD, Lee CO. Partial rescue of the Na+-Ca2+ exchanger (NCX1) knock-out mouse by transgenic expression of NCX1. Exp Mol Med. 2003;35(2):125–35. doi: 10.1038/emm.2003.18 12754417.

54. Knofler M, Haider S, Saleh L, Pollheimer J, Gamage T, James J. Human placenta and trophoblast development: key molecular mechanisms and model systems. Cell Mol Life Sci. 2019;76(18):3479–96. doi: 10.1007/s00018-019-03104-6 31049600; PubMed Central PMCID: PMC6697717.

55. Holmyard D, Lazzarini RA, Cross JC, Fisher SJ, Dawson K, Anson-Cartwright L. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nature Genetics. 2000;25(3):311–4. doi: 10.1038/77076 10888880

56. Li W, Zheng X, Gu JM, Ferrell GL, Brady M, Esmon NL, et al. Extraembryonic expression of EPCR is essential for embryonic viability. Blood. 2005;106(8):2716–22. doi: 10.1182/blood-2005-01-0406 15956290; PubMed Central PMCID: PMC1895308.


Článek vyšel v časopise

PLOS Genetics


2020 Číslo 4
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Hypertenze a hypercholesterolémie – synergický efekt léčby
nový kurz
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Multidisciplinární zkušenosti u pacientů s diabetem
Autoři: Prof. MUDr. Martin Haluzík, DrSc., prof. MUDr. Vojtěch Melenovský, CSc., prof. MUDr. Vladimír Tesař, DrSc.

Úloha kombinovaných preparátů v léčbě arteriální hypertenze
Autoři: prof. MUDr. Martin Haluzík, DrSc.

Halitóza
Autoři: MUDr. Ladislav Korábek, CSc., MBA

Terapie roztroušené sklerózy v kostce
Autoři: MUDr. Dominika Šťastná, Ph.D.

Všechny kurzy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#